Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Teva Pharmaceutical Industries Limited (TEVA)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
8.07+0.25 (+3.20%)
At close: 04:00PM EDT
8.06 -0.01 (-0.12%)
After hours: 07:51PM EDT
Advertisement

Yahoo Finance will soon be upgrading our Conversations message board platform to provide a better experience for our users. Only comments published since April 21, 2021 will be visible on Yahoo Finance after the upgrade. If you wish to download and save any of your older comments, please submit a request via the Privacy Dashboard by no later than Sept. 30.

Sign in to post a message.
  • y
    y
    Shorts are posting in full force, always a good sign!
    Bullish
  • O
    Ole
    It would be informative if Teva provided information on the further process regarding Opioid cases
  • f
    felix
    after adding shares for years and more then doubling my position last time TEVA hit 10.40, i feel that i have to keep buying big because the upside is much bigger than down side......i will admit that every time i bought i thought the upside was bigger then down side and i am down on paper on most of my buys so far.....hopefully TEVA sp will change direction in the new year.....Shana Tova everyone (Happy New Year).....
  • I
    IQ-Investment-TW
    3 days left till final draft ready (and possible inclusion of NY).
  • J
    Julian
    I love starting my day with the daily emails from http://alert-sounds.com/. They equip me with what I need to make wiser investment decisions!
  • y
    y
    The final draft of the settlement is set to be finished end of September according to CEO. That will pop the stock. Then once it’s signed off on anytime from 10/1-12/31 the stock will fly.
  • G
    Gabriel
    what does a Georgia settlement mean for the stock price? nothing as usual. lol
  • M
    Michael
    October 1….. no settlement documents yet(smh)
  • y
    y
    On 8/5/22

    Teva Pharmaceutical upgraded to buy from neutral at BofA Securities

    That should tell you all you need to know.
    Bullish
  • p
    puja
    Schultz talked about financial goals for the coming years. "Up to 2027, the profit margins will continue to improve, the debt will continue to fall, by $10-12 billion, and the new item is growth in revenue. We won’t make large acquisitions, but we will make licensing agreements for products, including products at advanced stages. All in all we have created a sustainable base for a return to growth. Of course we are not happy with the present level of the stock, but we believe that we are in a good position for the future. We are convinced that the ‘penalty’ on our valuation because of the legal proceedings will eventually disappear."
  • s
    søren
    LIke i sad the other day - I think this is the bottom for Teva now. But I dont think we will hear any news soon.
  • s
    søren
    So the news is today ? End off Sep ? NO::
  • y
    y
    "Teva has one of the lowest P/E ratios of any share I know, and the business is actually very stable, that will grow long term and generate cash - so it's very good for long term investors," the report quoted Schultz. He suggested that the low share price largely stemmed from high debt, which has come down to $20 billion from $34 billion, and the opioid litigation.
    Bullish
  • s
    skrewball
    I wonder why schultz is leaving at the end of his contract for a board position? Also, teva will continue to pay down debt and generate profit. But closing 10 more manufacturing plants over a certain time period and with the USD getting stronger conversion rates will hurt teva. I feel like there is a reason why he is leaving. This screams what happened when Schultz left Lundbeck pharma all over again.
  • J
    Joel
    Never been this overweight in a stock since I loaded up BAC @ 7 bucks a share hope the outcome will be the same. I said I would and added more shares today.
  • T
    Tsahi
    Teva Reaches Agreement With Georgia to Settle the State’s Price Fixing Claims

    September 30, 2022
    TEL AVIV, Israel & PARSIPPANY, N.J.--(BUSINESS WIRE)-- Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), has reached an agreement with the Attorney General (AG) of Georgia to settle the state’s price-fixing claims against Teva. Teva will pay the state $3.346 million as part of the settlement, and the state will dismiss all of its claims against Teva and its affiliates once payment has been made.

    Source: Teva mail
  • i
    i_felonious
    i see nothing has changed in Tevaville
  • t
    thenextwarrentbuffett
    new york attorney general after trump not resolving TEVA litigation
    Bullish
  • T
    Tsahi
    Teva Pharmaceutical: Slow And Steady Road To A Higher Share Price

    Summary
    Teva is a solid company which faces/faced headwinds from their high debt load and opioid crisis settlement uncertainty.

    But with most of the settlement uncertainty behind them and their efforts to significantly lower their debt, their current valuation doesn't make sense.

    As a result, I believe a 25% to 35% averaged annual return is possible through 2025 to 2026, leading to an increasingly bullish stance on Teva's long-term prospects.

    source:
    Seeking Alpha, Pinxter Analytics
    Bullish
  • s
    søren
    We will not hear anything from Teva before ER - Boom...
Advertisement
Advertisement